Naturheilpraxis, Volume 69, July 2016
(Translated by Carolyn L. Winsor)

Pandemrix Vaccinations

In future those affected persons In Sweden who suffer from incurable narcolepsy as a consequence of the swine flu vaccination with the vaccine Pandemrix, can claim a maximum up to 10 million Swedish Krona (one million Euro) in compensation. A corresponding law was recently initiated by the Parliament in Stockholm. Altogether in Sweden 475 patients claimed compensation, of which 311 cases were granted. Leading symptoms of the narcolepsy are persistent daytime drowsiness, imperative sleep attacks and cataplexy, sudden tone loss of the supporting musculature which is triggered by sudden strong feelings. Pandemrix was permitted in September 2009 in the European Union for the prevention of an infection with the virus strain H1N1/v. During the influenza wave of 2009/2010 nearly 31 million persons were vaccinated with it, and there were also vaccines from other conglomerates. In Sweden 60 percent could be vaccinated. In Germany according to the Paul-Ehrlich Institute up to 81 suspicious cases were recorded. A portion of those patients also demand compensation.

Source:
Pharmazeutische Zeitung online unter: http://bit.ly/1TneRBg
doi: 10.1136/medium-2015-010684
doi: 10.1111/joim.12391.

A Point of Interest for OIRF Supporters
From THE BRIDGE Newsletter of OIRF
Published August 2016

© Reprinted from Naturheilpraxis, Vol. 69, July 2016

Related Articles

  • MORA

    MORA takes another step toward Canadian Registration! Recently the Med-Tronik firm underwent their regular ISO audit for manufacture of medical devices under the 13485 [...]

  • 80 Years Later?

    POINTS OF INTEREST The era of cancer chemotherapy was first developed at the beginning of the 20th century, although it was not originally intended [...]

  • Global Burden of Cancers

    POINTS OF INTEREST Global burden of cancers attributable to infections in 2008: a review and synthetic analysis Catherine de Martel MD, Jacques Ferlay ME, [...]

  • Interview

    And, to remind ourselves why we all do this . . . This is part of an interview done for the newsletter of a [...]

Sign-up to receive updates sent straight to your inbox